Trial intelligence / Profile preview

Injectable Platelet Rich Fibrin vs Corticosteroids for Oral Lichen Planus

NCT03265093Completed

Sponsor
Bezmialem Vakif University
Start
May 2017
Primary completion
Sep 2019
Modality
Device-based Delivery
Countries
1
01

Overview

Randomised, open-label trial of injectable platelet-rich fibrin in oral lichen planus (OLP) (2 arms), sponsored by Bezmialem Vakif University. Primary endpoints: Visual Analog Scale at 6 months, Thongprasom sign scoring system at 6 months and 1 more. Started May 2017; status: completed.

02

Drugs

injectable platelet-rich fibrin
03

Conditions

oral lichen planus (OLP)

Beyond the preview

Go deeper on NCT03265093.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03265093.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call